NRX Pharmaceuticals (NASDAQ:NRXP) just reported results for the fourth quarter of 2023.
- NRX Pharmaceuticals reported earnings per share of -5 cents. This was above the analyst estimate for EPS of -7 cents.
- The company did not report any revenue for the quarter.